• 

  Covid vaccination drive in India to kick off on January 16 | Key points

  India | January 10, 2021 8:16 IST

  The vaccination drive against coronavirus will kick off on January 16, 2021. The priority will be given to the healthcare workers and the frontline workers, estimated to be around 3 crore, followed by those above 50 years and the under-50 population groups with co-morbidities numbering around 27 crore, the government said on Saturday.

• 

  Watch how Fake News Spread Misinformation About The COVID-19 Vaccine

  News | January 08, 2021 18:35 IST

  As India gets closer to mass vaccination nation-wide rollout, it must brace up to tackle vaccine misinformation on a war footing.

• 

  Special News: 2nd vaccination dry run across the country today

  News | January 08, 2021 16:18 IST

  A second dry run to check the best way to vaccinate people against COVID-19 is taking place across 737 districts in the country today.

• 

  We are global company, don't accuse us of inexperience: Bharat Biotech strong message to critics

  News | January 04, 2021 19:17 IST

  The chairman of Bharat Biotech - whose coronavirus vaccine Covaxin was yesterday given 'restricted use in emergency situation in public interest' - hit out today at critics querying the lack of Phase III trial data and others questioning the drug's efficacy.

• 

  Bharat Biotech slams criticism of indigenous vaccine Covaxin; we are a global company, says CMD

  India | January 04, 2021 23:02 IST

  Speaking during a virtual press conference, Bharat Biotech MD Krishna Ella sought to clear all doubts over the much awaited vaccine against coronavirus and asserted that he has no political connections.

• 

  Bharat Biotech's Covaxin cleared for conducting clinical trials on children

  India | January 04, 2021 14:38 IST

  The Drugs Controller General of India (DCGI) has given licensing permission to Hyderabad-based Bharat Biotech to manufacture 'Covaxin' for sale and distribution. The DCGI approval document said the firm can vaccinate children above the age of 12 years during the clinical trial mode.

• 

  Is it safe for cancer, diabetic patients to take COVID-19 vaccine? Details here

  India | January 04, 2021 10:50 IST

  The Serum Institute of India, the world's largest vaccine manufacturer, has tied up with AstraZeneca to manufacture Covishield, while Covaxin has been indigenously developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR).

• 

  Bharat Biotech gets licensing permission to manufacture Covaxin

  India | January 03, 2021 21:24 IST

  The Central Licensing Authority on Sunday granted permission to Bharat Biotech to manufacture Covaxin for sale and distribution, hours after the Drug Controller General of India (DCGI) approved the coronavirus vaccine for restricted emergency use.

• 

  Covaxin generated excellent safety data, says Bharat Biotech

  India | January 03, 2021 20:48 IST

  Bharat Biotech claimed on Sunday that its vaccine generated excellent safety data with robust immune responses to multiple viral proteins that persist.

• 

  Kurukshetra: The political war over indigenous Covid19 vaccine has started

  Kurukshetra | January 03, 2021 23:31 IST

  Drug Controller General of India (DCGI) on Sunday approved Serum Institute of India's 'Covishield' vaccine and Bharat Biotech's 'Covaxin' for emergency use against coronavirus.

• 

  What Does ‘Emergency Use’ Mean as India Gets Two COVID-19 Vaccines

  News | January 03, 2021 19:55 IST

  Drug Controller General of India (DCGI) on Sunday approved Serum Institute of India's 'Covishield' vaccine and Bharat Biotech's 'Covaxin' for emergency use against coronavirus.

Advertisement
• 

  Covid vaccine is here! Serum Institute, Bharat Biotech get approval for restricted use in India

  News | January 03, 2021 16:27 IST

  In a significant development, Drugs Controller General of India (DGCI) on Sunday (January 3) formally approved Oxford-AstraZeneca's Covishield and Bharat Biotech's Covaxin for use in India.

• 

  ‘Watershed moment' in India’s famed battle against Covid, hails health minister Harsh Vardhan

  India | January 03, 2021 14:03 IST

  Hours after India's drugs regulator approved Oxford COVID-19 vaccine Covishield, manufactured by the Serum Institute, and indigenously developed Covaxin of Bharat Biotech for restricted emergency use in the country, Union Health Minister Dr. Harsh Vardhan on Sunday called it a "watershed moment" in India’s famed battle against COVID-19.

• 

  'Absolute rubbish': DCGI on impotency rumours, says Covid vaccines 110% safe

  India | January 03, 2021 13:17 IST

  As India gears up for the world's largest vaccination programme, the Drugs Controller General of India (DCGI) on Sunday quelled rumours surrounding the COVID-19 vaccines regarding impotency, rubbishing such speculations as "absolute nonsense".

• 

  WHO welcomes first emergency use authorization to COVID-19 vaccine in India

  India | January 03, 2021 12:06 IST

  The approved vaccines will be first offered to one crore healthcare workers, along with two crore frontline and essential workers and 27 crore elderly, mostly above the age of 50 years with co-morbidities.

• 

  Would make every Indian proud: PM Modi on DCGI's final approval to Covishield, Covaxin

  India | January 03, 2021 12:08 IST

  Covid-19 vaccines- COVAXIN and COVISHIELD have been cleared for restricted use in emergency situation, DCGI, V G Somani said.

• 

  Covishield, Covaxin get govt's nod: DCGI's Full Statement

  India | January 03, 2021 12:07 IST

  The expert panel has recommended granting permission for restricted emergency use of 'Covaxin' in "public interest as an abundant precaution, in clinical trial mode, especially in the context of infection by mutant strains.

• 

  Covid vaccine is here! Serum Institute, Bharat Biotech get approval

  India | January 03, 2021 11:56 IST

  In a significant development, Drugs Controller General of India (DGCI) on Sunday (January 3) formally approved Oxford-AstraZeneca's Covishield and Bharat Biotech's Covaxin for use in India.

• 

  AIDAN asks DCGI to withdraw approval for Bharat Biotech's Covaxin

  India | January 03, 2021 8:01 IST

  The AIDAN has said it is shocked to learn about the recommendation to grant REU approval to Bharat Biotech's COVAXIN in "clinical trial mode" and "specially in the context of infection by mutant strains".

• 

  Bharat Biotech recruits 23,000 volunteers for Phase III trials of Covaxin

  India | January 02, 2021 22:41 IST

  Bharat Biotech on Saturday announced successful recruitment of 23,000 volunteers, and continued progress towards achieving the goal of 26,000 participants for phase-III clinical trial of its coronavirus vaccine 'Covaxin' across multiple sites in India.